Shareholdings
| Concept |
As at 2025-03-31 |
2024-04-01 to 2025-03-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Investment shares held for purposes other than pure investment | ||
| Shares not listed | ||
| Number of issues |
42
xbrli:pure
|
— |
| Carrying amount |
11,286,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
6
xbrli:pure
|
| Total acquisition cost for increased shares | — |
2,487,000,000
JPY
|
| Reason for increase in number of shares | — |
・一層の取引強化のため
・医薬品事業戦略及びエコシステム戦略における関係性の維持・強化のため
|
| Number of issues whose number of shares decreased | — |
3
xbrli:pure
|
| Total sale amount for decreased shares | — |
2,527,000,000
JPY
|
| Shares other than those not listed | ||
| Number of issues |
7
xbrli:pure
|
— |
| Carrying amount |
22,402,000,000
JPY
|
— |
| Number of issues whose number of shares increased | — |
1
xbrli:pure
|
| Total acquisition cost for increased shares | — |
JPY
|
| Reason for increase in number of shares | — |
・上場に伴う区分変更
|
| Number of issues whose number of shares decreased | — |
2
xbrli:pure
|
| Total sale amount for decreased shares | — |
399,000,000
JPY
|